---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-000708"
form_type: "8-K"
ticker: "PRCT"
cik: "0001588978"
company_name: "PROCEPT BioRobotics Corp"
filed_at: "2022-01-11T23:59:59+00:00"
generated_at: "2026-06-27T18:59:07.426645+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# PROCEPT BioRobotics announces preliminary Q4 revenue of $9.8-10.1M, FY 2021 revenue $34.1-34.4M

## Summary
- Q4 2021 revenue expected $9.8M-$10.1M, up from $3.2M in Q4 2020.
- FY 2021 revenue expected $34.1M-$34.4M, up from $7.7M in FY 2020.
- U.S. Q4 revenue $8.4M-$8.7M; systems $5.0M, consumables $3.4M; international $1.4M.
- CEO states results exceeded expectations due to system sales, procedure adoption, and commercial team expansion.

## SEC filing metadata
- accession: 0001628280-22-000708
- form_type: 8-K
- ticker: PRCT
- cik: 0001588978
- company_name: PROCEPT BioRobotics Corp
- filed_at: 2022-01-11T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1588978/000162828022000708/0001628280-22-000708-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1588978/000162828022000708/prct-20220111.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-000708
- JSON: https://secwatch.observer/filing/0001628280-22-000708.json
- Plain text: https://secwatch.observer/filing/0001628280-22-000708.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.